Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide).
Sintsova O, Popkova D, Kalinovskii A, Rasin A, Borozdina N, Shaykhutdinova E, Klimovich A, Menshov A, Kim N, Anastyuk S, Kusaykin M, Dyachenko I, Gladkikh I, Leychenko E.
Sintsova O, et al. Among authors: kusaykin m.
Biomed Pharmacother. 2023 Dec;168:115743. doi: 10.1016/j.biopha.2023.115743. Epub 2023 Oct 18.
Biomed Pharmacother. 2023.
PMID: 37862974
Free article.